metoclopramide has been researched along with Amyloidosis in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reddy, AB | 1 |
| Wright, RA | 1 |
| Wheeler, GE | 1 |
| Nazer, H | 1 |
1 other study available for metoclopramide and Amyloidosis
| Article | Year |
|---|---|
Nonobstructive gastroparesis in amyloidosis improved with metoclopramide.
Topics: Aged; Amyloidosis; Female; Gastric Emptying; Gastrointestinal Motility; Humans; Male; Metoclopramide | 1983 |